2023
DOI: 10.1016/j.msard.2023.105096
|View full text |Cite
|
Sign up to set email alerts
|

Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability

Mantas Vaisvilas,
Gintaras Kaubrys,
Rasa Kizlaitiene
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 30 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?